Plexus (PLXS) Q4 2026 Earnings Call Transcript

Plexus reported fiscal Q4 2026 revenue of $1.43 billion, up 35% year over year, and non-GAAP diluted EPS of $2.84, above its $2.47–$2.63 guidance range; fiscal 2026 revenue rose 23% to about $5.0 billion. Management raised its fiscal 2027 revenue growth outlook to the mid-to-upper teens, set a new 6.5%–7.0% operating-margin goal, and expects more than $100 million in free cash flow; the board approved a $100 million fiscal 2027 share repurchase program. The $4.9 billion manufacturing opportunity funnel reached a record, while management flagged challenged materials availability and low-single-digit industrial-sector revenue decline in fiscal Q1.

Analysis

The key underwriting issue is conversion, not demand: annualized wins and the opportunity funnel are not backlog, and material shortages can delay ramps while leaving labor and fixed-cost leverage exposed. That makes PLXS’s margin target more execution-sensitive than the headline growth outlook suggests. If supply access holds, automation and higher utilization can compound operating leverage without proportionate capex; if parts remain constrained, revenue can slip while working capital is tied up ahead of shipment.

The mix is also a partial hedge, not full diversification. Semiconductor capital equipment and defense/space strength offsets near-term communications normalization, but both growth engines are exposed to customer program timing and, over a longer horizon, cyclical or budget-driven pauses. The conservative exclusion of a meaningful Boeing recovery limits upside optionality but reduces reliance on an uncertain ramp. Compared with larger EMS competitors such as Flex and Jabil, PLXS’s differentiated opportunity is execution in complex, regulated programs; the risk is that wins take time to translate into consolidated earnings.

Near term, a strong initial reaction could overcapitalize the FY27 growth and new margin goal before cash conversion is demonstrated. Over 1–3 months, watch Q1 revenue conversion, gross margin versus the 9.7%–10.0% guide, and cash-cycle progression. Over 6–18 months, the test is whether efficiency gains sustain margins as growth investments and working-capital needs rise. Thesis weakens if program ramps repeatedly slip, margin progress stalls below the new goal, or cash generation misses the stated FY27 floor.

Key Decisions for Investors

• For existing exposure, retain a constructive but measured stance; consider adding in stages after the initial earnings reaction rather than chasing a gap, since funnel and wins are not near-term revenue commitments.
• Use Q1 results as the first confirmation point: track revenue against guidance, gross margin against 9.7%–10.0%, and whether the cash cycle moves back toward the low-to-mid 60-day FY27 expectation after the seasonal increase.
• Treat the FY27 free-cash-flow outlook as conditional on working-capital discipline. Reassess if growth requires materially more inventory funding than management’s stated 15–20 cents per dollar of revenue growth, or if cash generation falls short of the $100 million target.
• Avoid a near-term peer pair trade without relative valuation and estimate data. Watch Flex and Jabil disclosures for evidence that PLXS’s share gains in semiconductor capital equipment and complex programs are translating into durable relative outperformance.